Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 123,436 | 96,576 | 55,030 | 85,305 | N/A |
| Marketable Securities | 564,833 | 480,290 | 109,988 | 106,845 | N/A |
| Receivables | 10,047 | 12,676 | 4,807 | 5,582 | N/A |
| Inventories | 14,063 | 9,069 | 7,838 | 4,792 | N/A |
| TOTAL | $726,914 | $612,690 | $180,718 | $205,247 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 39,692 | 60,355 | 19,125 | 13,954 | N/A |
| Investments And Advances | 118,525 | 105,435 | 0 | 8,905 | 0 |
| Intangibles | 129,197 | 130,900 | 132,598 | 134,297 | 0 |
| Other Non-Current Assets | 102,086 | 2,922 | 247 | 86 | 0 |
| TOTAL | $389,500 | $299,612 | $151,970 | $157,242 | $N/A |
| Total Assets | $1,116,414 | $912,302 | $332,688 | $362,489 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,237 | 4,453 | 1,793 | 1,964 | 0 |
| Accrued Expenses | 25,112 | 12,495 | 7,203 | 4,105 | N/A |
| TOTAL | $105,197 | $78,313 | $22,800 | $21,003 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 36,607 | N/A | N/A | N/A |
| Deferred Revenues | 73,319 | 61,365 | 13,804 | 14,934 | N/A |
| Other Non-Current Liabilities | 104,333 | 93 | 336 | 375 | 0 |
| TOTAL | $267,951 | $262,950 | $7,142 | $4,769 | $N/A |
| Total Liabilities | $373,148 | $341,263 | $29,942 | $25,772 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 139,220 | 126,318 | N/A | N/A | N/A |
| Common Shares | 14 | 12 | 1 | 1 | N/A |
| Retained earnings | -511,612 | -365,478 | -295,908 | -249,423 | N/A |
| Other shareholders' equity | 893 | 671 | 560,751 | 561,167 | 0 |
| TOTAL | $743,266 | $571,039 | $302,746 | $336,717 | $N/A |
| Total Liabilities And Equity | $1,116,414 | $912,302 | $332,688 | $362,489 | $0 |